Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COAG compared with GHRS: revenue, margins and what each company keeps, and the suppliers and customers both name
COAG
Hemab Therapeutics Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
GHRS
GH Research PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
COAG
Hemab Therapeutics Holdings, Inc.
vs
GHRS
GH Research PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
COAG: latest quarter not drawable. GHRS: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
COAG, solid
GHRS, dashed
COAG
Hemab Therapeutics Holdings, Inc.
Change
41.49
▲
+2.65%
· post 41.49
Mkt cap
$1.2B
GHRS
GH Research PLC
Change
20.67
▼
−3.86%
· post 20.67
Closed
Oct 30 '26
Mkt cap
$1.3B
vs
Compare
Closed
Oct 30 '26
COAG
Hemab Therapeutics Holdings, Inc.
vs
GHRS
GH Research PLC
41.49
▲
+2.65%
post 41.49
Price
20.67
▼
−3.86%
post 20.67
$1.2B
Mkt cap
$1.3B
Change
Change
COAG
41.49
▲
+2.65%
vs
GHRS
20.67
▼
−3.86%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only COAG
2
NVO
Novo Nordisk A/S
supplier
GMAB
Genmab A/S
supplier
Shared
0
No disclosed counterparties: GHRS.
Only GHRS
0
None
Role chip = supplier or customer
Source: SEC EDGAR